320 related articles for article (PubMed ID: 20818871)
1. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.
Stahl R; Hoxha E; Fechner K
N Engl J Med; 2010 Jul; 363(5):496-8. PubMed ID: 20818871
[No Abstract] [Full Text] [Related]
2. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.
Debiec H; Ronco P
N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563
[No Abstract] [Full Text] [Related]
3. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
5. Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.
Cravedi P; Ruggenenti P; Remuzzi G
J Am Soc Nephrol; 2011 Aug; 22(8):1400-2. PubMed ID: 21784892
[No Abstract] [Full Text] [Related]
6. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of membranous nephropathy: evolution and revolution.
Glassock RJ
Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
[TBL] [Abstract][Full Text] [Related]
9. Human idiopathic membranous nephropathy--a mystery solved?
Glassock RJ
N Engl J Med; 2009 Jul; 361(1):81-3. PubMed ID: 19571287
[No Abstract] [Full Text] [Related]
10. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].
Kozioł M; Sikora A; Kozioł-Montewka M; Smarz-Widelska I; Orłowska-Kowalik G; Pyszna W; Załuska W; Ksiazek A
Pol Merkur Lekarski; 2014 Mar; 36(213):171-4. PubMed ID: 24779214
[TBL] [Abstract][Full Text] [Related]
12. Management of Membranous Nephropathy in the PLA
Bomback AS
Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770
[No Abstract] [Full Text] [Related]
13. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
Hu R; Xing G; Wu H; Zhang Z
Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy.
Huang X; Qin W; Zhang M; Zheng C; Zeng C; Liu Z
Am J Med Sci; 2013 Jul; 346(1):32-7. PubMed ID: 23103439
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-PLA2R and recurrent membranous nephropathy: another piece of the puzzle.
Beck LH
J Am Soc Nephrol; 2012 Dec; 23(12):1911-3. PubMed ID: 23138482
[No Abstract] [Full Text] [Related]
17. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor.
Debiec H; Hanoy M; Francois A; Guerrot D; Ferlicot S; Johanet C; Aucouturier P; Godin M; Ronco P
J Am Soc Nephrol; 2012 Dec; 23(12):1949-54. PubMed ID: 23123401
[TBL] [Abstract][Full Text] [Related]
18. Very early recurrence of anti-Phospholipase A2 receptor-positive membranous nephropathy after transplantation.
Blosser CD; Ayalon R; Nair R; Thomas C; Beck LH
Am J Transplant; 2012 Jun; 12(6):1637-42. PubMed ID: 22390840
[TBL] [Abstract][Full Text] [Related]
19. Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.
Kattah A; Ayalon R; Beck LH; Sethi S; Sandor DG; Cosio FG; Gandhi MJ; Lorenz EC; Salant DJ; Fervenza FC
Am J Transplant; 2015 May; 15(5):1349-59. PubMed ID: 25766759
[TBL] [Abstract][Full Text] [Related]
20. Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
Hofstra JM; Wetzels JF
Neth J Med; 2012 Apr; 70(3):109-13. PubMed ID: 22516574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]